Literature DB >> 25808929

Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation.

Karen J Gregory1, P Jeffrey Conn2.   

Abstract

The metabotropic glutamate (mGlu) receptors are a group of eight family C G protein-coupled receptors that are expressed throughout the central nervous system (CNS) and periphery. Within the CNS the different subtypes are found in neurons, both pre- and/or postsynaptically, where they mediate modulatory roles and in glial cells. The mGlu receptor family provides attractive targets for numerous psychiatric and neurologic disorders, with the majority of discovery programs focused on targeting allosteric sites, with allosteric ligands now available for all mGlu receptor subtypes. However, the development of allosteric ligands remains challenging. Biased modulation, probe dependence, and molecular switches all contribute to the complex molecular pharmacology exhibited by mGlu receptor allosteric ligands. In recent years we have made significant progress in our understanding of this molecular complexity coupled with an increased understanding of the structural basis of mGlu allosteric modulation.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25808929      PMCID: PMC4468636          DOI: 10.1124/mol.114.097220

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  148 in total

1.  Intracellular mGluR5 can mediate synaptic plasticity in the hippocampus.

Authors:  Carolyn A Purgert; Yukitoshi Izumi; Yuh-Jiin I Jong; Vikas Kumar; Charles F Zorumski; Karen L O'Malley
Journal:  J Neurosci       Date:  2014-03-26       Impact factor: 6.167

2.  Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.

Authors:  Yuji Odagaki; Masakazu Kinoshita; Ryoichi Toyoshima
Journal:  Basic Clin Pharmacol Toxicol       Date:  2011-05-05       Impact factor: 4.080

3.  Structure of a class C GPCR metabotropic glutamate receptor 1 bound to an allosteric modulator.

Authors:  Huixian Wu; Chong Wang; Karen J Gregory; Gye Won Han; Hyekyung P Cho; Yan Xia; Colleen M Niswender; Vsevolod Katritch; Jens Meiler; Vadim Cherezov; P Jeffrey Conn; Raymond C Stevens
Journal:  Science       Date:  2014-03-06       Impact factor: 47.728

4.  Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAM.

Authors:  Douglas J Sheffler; Cody J Wenthur; Joshua A Bruner; Sheridan J S Carrington; Paige N Vinson; Kiran K Gogi; Anna L Blobaum; Ryan D Morrison; Mitchell Vamos; Nicholas D P Cosford; Shaun R Stauffer; J Scott Daniels; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2012-04-30       Impact factor: 2.823

Review 5.  Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction.

Authors:  Khaled Moussawi; Peter W Kalivas
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

6.  Syntheses and pharmacological characterization of novel thiazole derivatives as potential mGluR5 PET ligands.

Authors:  Cindy A Baumann; Linjing Mu; Nicole Wertli; Stefanie D Krämer; Michael Honer; Pius A Schubiger; Simon M Ametamey
Journal:  Bioorg Med Chem       Date:  2010-06-25       Impact factor: 3.641

7.  Metabotropic glutamate receptors mGluR4 and mGluR8 regulate transmission in the lateral olfactory tract-piriform cortex synapse.

Authors:  Paulianda J Jones; Zixiu Xiang; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2008-06-29       Impact factor: 5.250

8.  Transposition of three amino acids transforms the human metabotropic glutamate receptor (mGluR)-3-positive allosteric modulation site to mGluR2, and additional characterization of the mGluR2-positive allosteric modulation site.

Authors:  Blake A Rowe; Hervé Schaffhauser; Sylvia Morales; Laura S Lubbers; Celine Bonnefous; Theodore M Kamenecka; Jeffrey McQuiston; Lorrie P Daggett
Journal:  J Pharmacol Exp Ther       Date:  2008-04-22       Impact factor: 4.030

9.  Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, noncompetitive antagonist of the metabotropic glutamate 1 receptor.

Authors:  Pari Malherbe; Nicole Kratochwil; Frédéric Knoflach; Marie-Thérèse Zenner; James N C Kew; Claudia Kratzeisen; Hans P Maerki; Geo Adam; Vincent Mutel
Journal:  J Biol Chem       Date:  2002-12-30       Impact factor: 5.157

10.  Activation and allosteric modulation of a muscarinic acetylcholine receptor.

Authors:  Andrew C Kruse; Aaron M Ring; Aashish Manglik; Jianxin Hu; Kelly Hu; Katrin Eitel; Harald Hübner; Els Pardon; Celine Valant; Patrick M Sexton; Arthur Christopoulos; Christian C Felder; Peter Gmeiner; Jan Steyaert; William I Weis; K Christopher Garcia; Jürgen Wess; Brian K Kobilka
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

View more
  17 in total

Review 1.  Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.

Authors:  K Sengmany; K J Gregory
Journal:  Br J Pharmacol       Date:  2015-11-11       Impact factor: 8.739

Review 2.  Novel Allosteric Modulators of G Protein-coupled Receptors.

Authors:  Patrick R Gentry; Patrick M Sexton; Arthur Christopoulos
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

3.  Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68).

Authors:  Xufen Yu; Xi-Ping Huang; Terry P Kenakin; Samuel T Slocum; Xin Chen; Michael L Martini; Jing Liu; Jian Jin
Journal:  J Med Chem       Date:  2019-08-01       Impact factor: 7.446

Review 4.  Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.

Authors:  Daniel J Foster; P Jeffrey Conn
Journal:  Neuron       Date:  2017-05-03       Impact factor: 17.173

5.  Differential Pharmacology and Binding of mGlu2 Receptor Allosteric Modulators.

Authors:  Daniel E O'Brien; Douglas M Shaw; Hyekyung P Cho; Alan J Cross; Steven S Wesolowski; Andrew S Felts; Jonas Bergare; Charles S Elmore; Craig W Lindsley; Colleen M Niswender; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2018-03-15       Impact factor: 4.436

Review 6.  Control of neuronal excitability by Group I metabotropic glutamate receptors.

Authors:  Ana Maria Bernal Correa; Jennifer Diniz Soares Guimarães; Everton Dos Santos E Alhadas; Christopher Kushmerick
Journal:  Biophys Rev       Date:  2017-08-23

7.  Development of 1H-Pyrazolo[3,4-b]pyridines as Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators.

Authors:  Matthew D Hill; Haiquan Fang; Jeffrey M Brown; Thaddeus Molski; Amy Easton; Xiaojun Han; Regina Miller; Melissa Hill-Drzewi; Lizbeth Gallagher; Michele Matchett; Michael Gulianello; Anand Balakrishnan; Robert L Bertekap; Kenneth S Santone; Valerie J Whiterock; Xiaoliang Zhuo; Joanne J Bronson; John E Macor; Andrew P Degnan
Journal:  ACS Med Chem Lett       Date:  2016-10-03       Impact factor: 4.345

8.  Design, Synthesis, and Characterization of [18F]mG2P026 as a High-Contrast PET Imaging Ligand for Metabotropic Glutamate Receptor 2.

Authors:  Gengyang Yuan; Maeva Dhaynaut; Nicolas J Guehl; Sepideh Afshar; Dalena Huynh; Sung-Hyun Moon; Suhasini M Iyengar; Manish Kumar Jain; Julie E Pickett; Hye Jin Kang; Mary Jo Ondrechen; Georges El Fakhri; Marc D Normandin; Anna-Liisa Brownell
Journal:  J Med Chem       Date:  2022-07-08       Impact factor: 8.039

9.  Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2.

Authors:  Brandon Wey-Hung Liauw; Arash Foroutan; Michael R Schamber; Weifeng Lu; Hamid Samareh Afsari; Reza Vafabakhsh
Journal:  Elife       Date:  2022-07-01       Impact factor: 8.713

10.  VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy.

Authors:  Hilary Highfield Nickols; Joannes P Yuh; Karen J Gregory; Ryan D Morrison; Brittney S Bates; Shaun R Stauffer; Kyle A Emmitte; Michael Bubser; Weimin Peng; Michael T Nedelcovych; Analisa Thompson; Xiaohui Lv; Zixiu Xiang; J Scott Daniels; Colleen M Niswender; Craig W Lindsley; Carrie K Jones; P Jeffrey Conn
Journal:  J Pharmacol Exp Ther       Date:  2015-10-26       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.